We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Nobel Prize Awarded for Fundamental Discoveries in Molecular Mechanisms of Cellular Vesicle Traffic

By LabMedica International staff writers
Posted on 14 Oct 2013
Print article
Image: 2013 Physiology or Medicine Nobel laureate Prof. Randy W. Schekman (Photo by H. Goren, courtesy of the Nobel Foundation; HHMI).
Image: 2013 Physiology or Medicine Nobel laureate Prof. Randy W. Schekman (Photo by H. Goren, courtesy of the Nobel Foundation; HHMI).
Image: 2013 Physiology or Medicine Nobel laureate Prof. James E. Rothman (Photo courtesy of the Nobel Foundation; Yale University).
Image: 2013 Physiology or Medicine Nobel laureate Prof. James E. Rothman (Photo courtesy of the Nobel Foundation; Yale University).
Image: 2013 Physiology or Medicine Nobel laureate Prof. Thomas C. Südhof (Photo courtesy of the Nobel Foundation; S. Fisch).
Image: 2013 Physiology or Medicine Nobel laureate Prof. Thomas C. Südhof (Photo courtesy of the Nobel Foundation; S. Fisch).
The 2013 Nobel Prize for Physiology or Medicine jointly awarded to scientists James E. Rothman, Randy W. Schekman, and Thomas C. Südhof recognizes the fundamental nature of their discoveries about how the cell organizes one of its major transport systems—about the machinery regulating vesicle traffic and the molecular principles that govern how this cellular cargo is precisely delivered to the right place at the right time.

Through their discoveries, they have revealed this exquisitely controlled system, the disturbance of which has deleterious effects and contributes to various medical disorders, including neurological diseases, diabetes, and immunological disorders. Prof. Schekman, currently at the University of California at Berkeley (USA) and an investigator of Howard Hughes Medical Institute (USA), discovered a set of genes required for vesicle traffic. Prof. Rothman, currently at Yale University (New Haven, CT, USA), unraveled protein machinery that allows vesicle membranes to fuse with their target membranes. Prof. Südhof, currently at Stanford University (CA, USA) and an investigator of Howard Hughes Medical Institute, revealed signals that instruct vesicles to release their cargo with precision.

The cell faces the problem of shipping to the right destination at the right time many types of molecules (including hormones, neurotransmitters, cytokines, and enzymes) to be transported and delivered to other locations in the cell or exported out. How do these vesicles know where and when to deliver their cargo?

Traffic congestion: Prof. Schekman was fascinated by how the cell organizes its transport system and in the 1970s decided to study its genetic basis by using yeast as a model system. In a genetic screen, he identified yeast cells with defective transport machinery, giving rise to vesicles piling up in certain parts of the cell. He found that the cause of this congestion was genetic and went on to identify the mutated genes. He identified three classes of genes that control different facets, thereby providing new insights into this tightly regulated machinery.

Docking: Prof. Rothman was also intrigued by the nature of the cell’s transport system. When studying vesicle transport in mammalian cells in the 1980s and 1990s, he discovered that a protein complex enables vesicles to dock and fuse with their target membranes. During fusion proteins on the vesicle and target membranes bind to each other like a zipper. The fact that there are many such proteins and that they bind only in specific combinations ensures that cargo is delivered to a precise location.

It turned out that some of the genes Prof. Schekman had discovered in yeast coded for proteins corresponding to those Prof. Rothman identified in mammals, revealing an ancient evolutionary origin of this transport system, which operates with the same general principles in yeast and humans. Collectively, they mapped critical components of this machinery.

Timing: Prof. Südhof was interested in how nerve cells communicate with one another in the brain. Synaptic vesicles release neurotransmitters upon nerve cell signaling to its neighbors. How is this controlled so precisely? Calcium ions were known to be involved and in the 1990s Prof. Südhof searched for calcium sensitive proteins in nerve cells. He identified molecular machinery that responds to an influx of calcium ions and directs neighbor proteins rapidly to bind synaptic vesicles to the outer membrane of the nerve cell. The zipper opens up and the contents are released. This explained how temporal precision is achieved and how vesicle contents can be released on command.

Together, these discoveries have had a major impact on our understanding of cellular transport mechanisms.

Related Links:

Nobel Foundation


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Cancer Mutation Profiling Liquid Kit
OncoScreen Plus

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.